Key result
Prior intracranial bleeding before LAAO is linked to ~327% higher in-patient mortality and increased complications.
Why the study?
Patients with a history of intracranial bleeding were excluded from large randomized clinical trials evaluating percutaneous left atrial appendage occlusion.
Does a history of intracranial bleeding increase in-hospital mortality and complications in atrial fibrillation patients undergoing percutaneous left atrial appendage occlusion?
Observational (n=89,300)
Yes
Does a history of intracranial bleeding increase in-hospital mortality and complications in atrial fibrillation patients undergoing percutaneous left atrial appendage occlusion?
In patients with atrial fibrillation undergoing LAAO, a history of intracranial bleeding is associated with significantly higher risks of in-hospital mortality, complications, and resource utilization.
Answers are grounded in this paper and cite their sources.
History of intracranial bleeding warrants caution in LAAO candidates; leaves open optimal periprocedural strategies for this subgroup.
BackgroundPercutaneous left atrial appendage occlusion (LAAO) has proved to be a safer alternative for long-term anticoagulation; however, patients with a history of intracranial bleeding were excluded from large randomized clinical trials.ObjectiveThe purpose of this study was to determine outcomes in atrial fibrillation (AF) patients with a history of intracranial bleeding undergoing percutaneous LAAO.MethodsNational Inpatient Sample and International Classification of Diseases, Tenth Revision, codes were used to identify patients with AF who underwent LAAO during the years 2016−2020. Patients were stratified based on a history of intracranial bleeding vs not. The outcomes assessed in our study included complications, in-hospital mortality, and resource utilization.ResultA total of 89,300 LAAO device implantations were studied. Approximately 565 implantations (0.6%) occurred in patients with a history of intracranial bleed. History of intracranial bleeding was associated with a higher prevalence of overall complications and in-patient mortality in crude analysis. In the multivariate model adjusted for potential confounders, intracranial bleeding was found to be independently associated with in-patient mortality (adjusted odds ratio [aOR] 4.27; 95% confidence interval [CI] 1.68–10.82); overall complications (aOR 1.74; 95% CI 1.36–2.24); prolonged length of stay (aOR 2.38; 95% CI 1.95–2.92); and increased cost of hospitalization (aOR 1.28; 95% CI 1.08–1.52) after percutaneous LAAO device implantation.ConclusionA history of intracranial bleeding was associated with adverse outcomes after percutaneous LAAO. These data, if proven in a large randomized study, can have important clinical consequences in terms of patient selection for LAAO devices. Percutaneous left atrial appendage occlusion (LAAO) has proved to be a safer alternative for long-term anticoagulation; however, patients with a history of intracranial bleeding were excluded from large randomized clinical trials. The purpose of this study was to determine outcomes in atrial fibrillation (AF) patients with a history of intracranial bleeding undergoing percutaneous LAAO. National Inpatient Sample and International Classification of Diseases, Tenth Revision, codes were used to identify patients with AF who underwent LAAO during the years 2016−2020. Patients were stratified based on a history of intracranial bleeding vs not. The outcomes assessed in our study included complications, in-hospital mortality, and resource utilization. A total of 89,300 LAAO device implantations were studied. Approximately 565 implantations (0.6%) occurred in patients with a history of intracranial bleed. History of intracranial bleeding was associated with a higher prevalence of overall complications and in-patient mortality in crude analysis. In the multivariate model adjusted for potential confounders, intracranial bleeding was found to be independently associated with in-patient mortality (adjusted odds ratio [aOR] 4.27; 95% confidence interval [CI] 1.68–10.82); overall complications (aOR 1.74; 95% CI 1.36–2.24); prolonged length of stay (aOR 2.38; 95% CI 1.95–2.92); and increased cost of hospitalization (aOR 1.28; 95% CI 1.08–1.52) after percutaneous LAAO device implantation. A history of intracranial bleeding was associated with adverse outcomes after percutaneous LAAO. These data, if proven in a large randomized study, can have important clinical consequences in terms of patient selection for LAAO devices.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2023) conducted an observational in Atrial fibrillation (n=89,300). History of intracranial bleeding vs. No history of intracranial bleeding was evaluated on In-patient mortality (aOR 4.27, 95% CI 1.68-10.82). A history of intracranial bleeding in AF patients undergoing LAAO was associated with higher in-patient mortality and overall complications.
Synapse has enriched 10 related papers. Consider them for comparative context: